CAS 36625-50-0

2-methyl-5-nitropyridine 1-oxide

Codes: EMOX-008

Application context (from source-drug indications)

Ischaemic strokeEthylmethylhydroxypyridine SuccinateOpen-angle glaucomaEthylmethylhydroxypyridine SuccinateAnxiety disorderEthylmethylhydroxypyridine SuccinateAttention deficit hyperactivity disorderEthylmethylhydroxypyridine Succinate脑缺血Ethylmethylhydroxypyridine Succinate

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
Ethylmethylhydroxypyridine Succinate	Tier C — Watch / trade	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Ethylmethylhydroxypyridine SuccinateOptimised routesteps: 6total yield: 100 mg

2-chloro-5-nitropyridine→diethyl 2-(5-nitropyridin-2-yl)malonate→2-methyl-5-nitropyridine→2-methyl-5-nitropyridine 1-oxide→2-ethyl-6-methyl-3-nitropyridine 1-oxide→2-ethyl-6-methylpyridin-3-amine

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.